⚠ Conduct, Mis-Selling & Regulatory BacklashModerate threat

A brand built on trust is uniquely vulnerable to conduct scandals, and a dominant, widely distributed insurer is a natural target for consumer regulators. Bancassurance and agent-sold products have a long, unhappy history of mis-selling — think of the unit-linked life policies sold across Europe with opaque fees and poor value, which drew regulatory crackdowns and customer restitution. PZU's very reach magnifies the risk: sell a flawed product through the largest network in the country and you have sold it to an enormous number of people.

The Polish financial regulator and consumer authorities have shown willingness to intervene on fees, product design, and sales practices, and the EU's insurance-distribution rules keep tightening. A conduct scandal would hit PZU twice: once in fines and restitution, and again — more lastingly — in the trust that is the entire point of the brand. For a company whose moat is substantially made of reputation, a serious mis-selling episode is not just a cost; it is an attack on the foundation, and the breadth of PZU's distribution — the channels serving nearly half the life market¹ — is exactly what would turn a product flaw into a systemic one.